If you have pernicious anemia, you'll have more trouble creating new blood cells and will require vitamin B12 supplementation
Kouichi Tamura has received honoraria/lecture fee from AstraZeneca, Novartes, Bayer, Otsuka Pharmaceutical, Boehringer Ingelheim, Fuji Pharma, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku, Mochida Pharmaceutical, Kowa, Eli Lilly, Novo Nordisk, commissioned clinical trials, contract research and joint research funding: AstraZeneca, Bayer, Novartis, Chinook, Otsuka Medical Devices, Novo Nordisk, Terumo, Variatris, and Kowa, and, Scholarship donations: Otsuka Pharmaceutical, Bayer, Mochida Pharmaceutical, and Boehringer Ingelheim
EMERALD LABS B-HEALTHY 120 VEG
Combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer
Niacin Time Release $28.80 Balance $29.90 Gi Complete Powder Lemon Lime $69.00 Gi Complete Capsules 300ct $69.00 Z-Binder $32.10 Probzyme Grape 90ct $49.50 SPM 120ct $129.50 cholesto Red 90ct $59.00 Reacted Iron $17.10 Her-T $50.00 Resvoxitrol $54.35 His-T $75.00 WholeMune $31.20 Vitamin K2 $38.60 NutraPack $58.00 Phytocidal $75.90 Buffered C Capsules $38.40 BioPC Pro $51.90 L-Carnitine $43.90 CDG EstroDim 60ct $49.40 CoQ-10 120ct $104.70
This suggests that KBP-089 is responsible for the majority of the efficacy of the combination therapy in this study
